Aim To asses relation of serum high sensitive C-reactive protein (hsCRP) level with albumin concentration in daily urine in patients with diabetes mellitus type 2 (T2DM). Methods The prospective study included 69 patients with T2DM, both sexes (24 males, 45 females), aged 30-82 years. They were divided into two groups: patients with T2DM and normoalbuminuria (T2DM-NA; n=40) and patients with T2DM and microalbuminuria (T2DM-MA; n=29). Patients were hospitalized at the Department of Internal Medicine, Cantonal Hospital Zenica, in the period January-April 2014. Immunonephelometry measurement of hsCRP was performed on the Nephelometer Analyzer BN II (Siemens, Germany). Results Frequency of patients in T2DM-NA and T2DM-MA groups was not significantly different in relation to sex and age. There was significant difference in relation to duration of diabetes ( p=0.001). Average glucose and HbA1c levels were significantly higher in T2DM-NA group comparing to T2DM-MA group (p=0.008 and p=0.047, respectively). Serum creatinine (p=0.011), urea (p=0.009) and hsCRP (p=0.005) were significantly higher in T2DM-MA group compared to T2DM-NA group. Urinary albumin showed significantly positive correlation with the hsCRP (rho=0.286; p=0.017), urea (rho=0.503) and creatinine (rho=0.438) (p<0.0005). A one unit (mg/L) increase in hsCRP concentration was associated with 11.5% increase of odds of microalbuminuria OR=1.115; 95% CI 1.014-1.225; p=0.025). Conclusion Significantly higher values of serum hsCRP in patients with type 2 diabetes mellitus and microalbuminuria in comparison to those with normoalbuminuria as well as the correlation of values of inflammatory marker with urinary albumin implicate a low grade inflammation in the progression of diabetic nephropathy.
Goud B, Nayal B, Devi O, Devaki R, Avinash S, Satisha T, et al. Comparison of microalbuminuria with hs-CRP and LDL levels in non-diabetic, non-hypertensive myocardial infarction patients. J Cardiovasc Dis Res. 2012;287–9.
2.
Pamungkas R, Chamroonsawasdi K. Vatanasomboon P. A systematic review: family support integrated with diabetes self-management among uncontrolled type II diabetes mellitus patients. Behav Sci. 2017;62.
3.
Vestra D, Mussap M, Gallina M, Bruseghin P, Cernigoi M, Saller A, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;
4.
Takebayashi K, Suetsugu M, Matsutomo R, Wakabayashi S, Aso Y, Inukai T. Correlation of highsensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes. South Med J. 2006;23–7.
5.
Mitrović M, Ilić T, Stokić E, Paro J, Naglić D, Bajkin I, et al. Influence of glucoregulation quality on C-reactive protein, interleukin-6 and tumor necrosis factor-alpha level in patients with diabetes type 1. Vojnosanit Pregl. 2011;756–61.
6.
Bosevski M, Bosevska G, Stojanovska L. Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report. Cardiovasc Diabetol. 2013;29.
7.
Wang Z, Hoy W, Wang Z. The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community. BMC Nephrol. 2013;176.
8.
Kshirsagar A, Bomback A, Bang H, Gerber L, Vupputuri S, Shoham D, et al. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys. Am J Cardiol. 1999;401–6.
9.
Bjornsson T. Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet. 1979;200–22.
10.
Meisinger C, Heier M, Landgraf R, Happich M, Wichmann H, Piehlmeier W, et al. cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study. BMC Health Serv Res. 2008;226.
11.
Patil V, Chaitanyakumar S, Patil V, Surpur R, Vijayanath V. Diabetic nephropathy and its relation to inflammation. Int J Pharm Bio Sci. 2013;117–27.
12.
Kassab A, Ajmi T, Issaoui M, Chaeib L, Miled A, Hammami M. Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes. Ann Clin Biochem. 2008;476–80.
13.
Sheikh S, Baig J, Iqbal T, Kazmi T, Baig M, Husain S. Prevalence of microalbuminuria with relation to glycemic control in type-2 diabetic patients in Karachi. J Ayub Med Coll Abbottabad. 2009;83–6.
14.
Swellam M, Mahmoud S, M, Ali AF, A. Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus. Dis Markers. 2009;269–78.
15.
Herder C, Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur J Clin Invest. 2011;679–92.
16.
Chavan V, Sayyed A, Durgawale P, Sontakke A, Nilakhe S. Practical aspects of calculation, expression and interpretation of urine albumin measurement. Natl J Integr Res Med. 2011;29–34.
17.
Adeqhate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1–29.
18.
Aggarwal J, Kumar M. Prevalence of microalbuminuria among rural North Indian population with diabetes mellitus and its correlation with glycosylated haemoglobin and smoking. J Clin Diagn Res. 2014;C11-13.
19.
Festa A, Agostino D, Howard R, G. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int. 2000;1703–10.
20.
Fox E, Benjamin E, Sarpong D. The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol. 2010;1.
21.
Mojahedi M, Bonakdaran S, Hami M, Sheikhian M, Shakeri, Aiatollahi H. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis. 2009;12–6.
22.
Yang S, Liu J, Yi B, Mao J, Zhang X, Liu Y, et al. Elevated high sensitivity C-Reactive protein increases the risk of microalbuminuria in subjects with cardiovascular disease risk factors. 2017;387–94.
23.
Liu Q, Jiang CY, Chen BX, Zhao W, Meng D. The association between high-sensitivity C-reactive protein concentration and diabetic nephropathy: a meta-analysis. Eur Rev Med Pharmacol Sci. 2015;4558–68.
24.
Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D. Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes. Niger J Clin Pract. 2013;216–20.
25.
Stehouwer C, Gall M, Twisk J, Knudsen E, Emeis J, Parving H. Increased urinary albumin excretion, endothelial dysfunction, and chronic lowgrade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 2002;1157–65.
26.
Hartge M, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res. 2007;84–8.
27.
Bhowmick K, Kutty A, Shetty H. Glycemic control modifies the association between microalbuminuria and C-reactive protein in type 2 diabetes mellitus. Indian J Clin Biochem. 2007;53–9.
28.
Asian J Pharm Clin Res. 2012;42–3.
29.
Prasad D, Rajaseker P. Study of microalbuminuria as a cardiovascular risk factor in type 2 diabetes mellitus.
30.
Nwaneri C, Cooper H, Bowen-Jones D. Mortality in Type 2 Diabetes Mellitus. Br J Diabetes Vasc Dis. 2013;192–207.
31.
Zakkerkish M, Shahbazian H, Shahbazian H, Latifi S. Moravej Aleali A. Albuminuria and its correlates in type 2 diabetic patients. Iran J Kidney Dis. 2013;268–76.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
